PATENT CLAIM ANALYSIS

Application Number: 15892247
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["530", "387100"]

Abstract:
The present invention relates to methods and compositions for use in inducing tumor-specific antibody mediated complement-dependent cytotoxic response in an animal having a tumor comprising administering to said animal a composition comprising a replication competent oncolytic virus wherein administration of the composition induces in the animal production of antibodies that mediate a CDC response specific to said tumor.

Claim (Index 10):
The method of  claim 9 , wherein the tumor is selected from colon cancer, rectal cancer, hepatocellular carcinoma, renal cell carcinoma, bladder cancer, lung cancer, stomach cancer, pancreatic cancer, melanoma, ovarian cancer, head and neck cancer, esophageal cancer, sarcoma and mesothelioma.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 88.0
- Lexical Diversity: 1.37209
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13535291', '14656397', '14876195', '14273476', '11470951']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6457966669932778
- 35 USC 102 Novelty (BERT): 0.5719140939630596
- Combined Prediction Score: 0.6384084096902559
- Mean Citation Score: 422.3317819999999
- Max Citation Score: 474.94214000000005
- Similarity Product: 355.9344162962187

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test